Online inquiry

IVTScrip™ mRNA-Human ARFGAP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23169MR)

This product GTTS-WK23169MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARFGAP1 protein. This product can be used in Lymphoid-primed multipotent progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001281482.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 55738
UniProt ID Q8N6T3
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARFGAP1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23169MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK9578MR IVTScrip™ mRNA-Human AFAP1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AFAP1
GTTS-WK12711MR IVTScrip™ mRNA-Human ACAP1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACAP1
GTTS-WK12589MR IVTScrip™ mRNA-Human AGAP3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AGAP3
GTTS-WK26852MR IVTScrip™ mRNA-Human ARMC1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARMC1
GTTS-WK14197MR IVTScrip™ mRNA-Human AC133, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AC133
GTTS-WK15020MR IVTScrip™ mRNA-Human AHCYL1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AHCYL1
GTTS-WK15830MR IVTScrip™ mRNA-Human ANKRD50, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD50
GTTS-WK16120MR IVTScrip™ mRNA-Human ANKRD36B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD36B
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW